KRYS
Krystal Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$310.84
+1.90%Forward multiples
Based on analyst estimates
- P/E forward
- 35.47x
- P/E 2026E
- 40.19x
- P/E 2027E
- 33.24x
- P/E 2028E
- 26.50x
- P/S forward
- 15.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- 40.58x
- PEG TTM
- 2.81x
- Price / book
- 6.42x
- Price / sales
- 19.60x
- Price / cash flow
- 28.44x
Enterprise value
- Enterprise value
- $8.3B
- EV / sales
- 17.68x
- EV / EBITDA
- 32.94x
- EV / EBIT
- 36.49x
- Market cap
- $9.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026